| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
group | 0.350 | None | 1.000 | 5 | 0 | 2005 | 2017 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
group | 0.320 | None | 1.000 | 5 | 0 | 2000 | 2014 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
group | 0.330 | None | 1.000 | 5 | 0 | 2000 | 2012 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
group | 0.370 | None | 1.000 | 5 | 0 | 1987 | 2013 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2020 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
clock circadian regulator | 0.463 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2003 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
group | 0.390 | None | 1.000 | 5 | 0 | 2010 | 2019 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
group | 0.360 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
group | 0.380 | None | 1.000 | 5 | 0 | 1987 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1979 | 1994 | |||||||||
|
adenylate cyclase 8 | 0.705 | 0.577 | 1.8E-06 |
|
group | 0.510 | None | 1.000 | 4 | 0 | 2009 | 2013 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
group | 0.310 | None | 1.000 | 4 | 0 | 2004 | 2010 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 1994 | 2000 | ||||||||
|
arginine vasopressin receptor 1B | 0.705 | 0.385 | 3.7E-04 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 2004 | 2013 | ||||||||
|
G protein-coupled receptor 50 | 0.686 | 0.462 | 0.65 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2005 | 2012 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.330 | None | 1.000 | 4 | 0 | 1998 | 2014 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1997 | 2019 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1982 | 2009 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2008 | 2018 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
prokineticin receptor 2 | 0.538 | 0.731 | 2.4E-06 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2009 | 2010 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2006 |